Quality of Life Assessment in Cancer Clinical Trials

摘要: Over the past decade there has been an increasing interest in broadening scope of evaluation parameters used clinical research oncology beyond traditional indicators therapeutic success such as prolonged survival, retardation disease process and control major physical symptoms. It argued that assessment efficacy cancer therapies requires greater attention to impact treatment on functional, psychological social health individual. While a range terms have applied this expanded focus, it is frequently subsumed under heading “quality life” research.